Cost-effectiveness analysis of guidelines for antihypertensive care in Finland |
| |
| Authors: | Neill Booth Antti Jula Pasi Aronen Minna Kaila Timo Klaukka Katriina Kukkonen-Harjula Antti Reunanen Pekka Rissanen Harri Sintonen Marjukka Mäkelä |
| |
| Affiliation: | (1) Tampere School of Public Health, University of Tampere, Tampere, Finland;(2) Department of Health and Functional Capacity, National Public Health Institute, Helsinki, Finland;(3) Finnish Office for Health Technology Assessment (FinOHTA), National Research and Development Centre for Welfare and Health (STAKES), Helsinki, Finland;(4) Department of Public Health, University of Helsinki, Helsinki, Finland;(5) Paediatric Research Centre, Tampere University Hospital and University of Tampere, Tampere, Finland;(6) Research Department, Social Insurance Institution, Helsinki, Finland;(7) UKK Institute for Health Promotion Research, Tampere, Finland;(8) University of Copenhagen, Copenhagen, Denmark |
| |
| Abstract: | Background Hypertension is one of the major causes of disease burden affecting the Finnish population. Over the last decade, evidence-based care has emerged to complement other approaches to antihypertensive care, often without health economic assessment of its costs and effects. This study looks at the extent to which changes proposed by the 2002 Finnish evidence-based Current Care Guidelines concerning the prevention, diagnosis, and treatment of hypertension (the ACCG scenario) can be considered cost-effective when compared to modelled prior clinical practice (the PCP scenario). |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
